SEARCH

SEARCH BY CITATION

References

  • 1
    Kalkstein TS, Kruger JM, Osborne CA. Feline idiopathic lower urinary tract disease: Part I. Clinical manifestations. Compend Contin Educ Prac Vet 1999;21:1526.
  • 2
    Kruger JM, Osborne CA, Lulich JP. Changing paradigms of feline idiopathic cystitis. Vet Clin Small Anim 2009;31:1540.
  • 3
    Rich LJ, Fabricant CG. Urethral obstruction in male cats: Transmission studies. Can J Comp Med 1969;33:164165.
  • 4
    Rich LJ, Fabricant CG, Gillespie JH. Virus induced urolithiasis in male cats. Cornell Vet 1971;61:542553.
  • 5
    Kruger JM, Osborne CA, Venta PJ, et al. Viral urinary tract infections. Vet Clin Small Anim 1996;26:281296.
  • 6
    Rice CC, Kruger JM, Venta PJ, et al. Genetic characterization of 2 novel feline caliciviruses isolated from cats with idiopathic lower urinary tract disease. J Vet Intern Med 2002;16:293302.
  • 7
    Evans AS. Causation and disease: The Henle-Koch postulates revisited. Yale J Biol Med 1976;49:175195.
  • 8
    Fenner F, Bachman PA, Gibbs EPJ, et al. Classification and nomenclature of viruses. Chapter 2 in Veterinary Virology. Orlando, FL: Academic Press Inc; 1987:2138.
  • 9
    Kalkstein TS, Kruger JM, Osborne CA. Feline idiopathic lower urinary tract disease: Part III. Diagnostic considerations. Compend Contin Educ Prac Vet 1999;21:387394.
  • 10
    Belliot G, Lavaux A, Souihel D, et al. Use of murine norovirus as a surrogate to evaluate resistance of human norovirus to disinfectants. Appl Environ Microbiol 2008;74:33153318.
  • 11
    Scansen BA, Kruger JM, Wise AG, et al. In vitro comparison of RNA preparation methods for detection of feline calicivirus in urine of cats by use of a reverse transcriptase-polymerase chain reaction assay. Am J Vet Research 2005;66:915920.
  • 12
    Scansen BA, Wise AG, Kruger JM, et al. Evaluation of a p30 gene-based real-time reverse transcriptase PCR assay for detection of feline calicivirus. J Vet Intern Med 2004;18:135138.
  • 13
    Povey C, Ingersoll J. Cross protection among feline caliciviruses. Infect Immun 1975;11:877885.
  • 14
    Johann JM, Caetano CF, Hass R, et al. Serum survey for antibodies to coronavirus, herpesvirus, calicivirus, and parvovirus in domestic cats from Rio Grande do Sul, Brazil. Arq Bras Med Vet Zootec 2009;61:752754.
  • 15
    Mouzin De, Lorenzen MJ, Haworth JD, et al. Duration of serologic response to three viral antigens in cats. J Am Vet Med Assoc 2004;224:6166.
  • 16
    Scott FW, Geissinger CM. Duration of immunity in cats vaccinated with an inactivated feline panleukopenia, herpesvirus, and calicivirus vaccine. Fel Prac 1997;25:1219.
  • 17
    Tham KM, Studdert MJ. Antibody and cell-mediated immune responses to feline calicivirus following inactivated vaccine and challenge. J Vet Med 1987;34:640654.
  • 18
    Wardley RC, Povey RC. The clinical disease and patterns of excretion associated with three different strains of feline calicivirus. Res Vet Sci 1976;23:714.
  • 19
    Pesavento PA, MacLachlan NJ, Dillard-Telm L, et al. Pathologic, immunohistochemical, and electronmicroscopic findings in naturally occurring virulent systemic feline calicivirus infection in cats. Vet Path 2004;41:257263.
  • 20
    Marsilio F, Martino B, Decaro N, et al. A novel nested PCR for the diagnosis of calicivirus infections in the cat. Vet Microbiol 2005;105:17.
  • 21
    Sykes JE, Studdert VP, Browning GF. Detection and strain differentiation of feline calicivirus in conjunctival swabs by RT-PCR of the hypervariable region of the capsid protein gene. Arch Virol 1998;143:13211334.
  • 22
    Wilhelm S, Truyen U. Real-time reverse transcription polymerase chain reaction assay to detect a broad range of feline calicivirus isolates. J Virol Methods 2006;133:105108.
  • 23
    Kleiboeker SB. Applications of competitor RNA in diagnostic reverse transcription-PCR. J Clin Microbiol 2003;41:20552061.
  • 24
    Kahn DE, Gillespie JH. Feline viruses: Pathogenesis of picornavirus infection in the cat. Am J Vet Res 1971;32:521531.
  • 25
    Povey RC, Wardley RC, Jessen H. Feline picornavirus infection; the in vivo carrier state. Vet Rec 1973;92:224229.
  • 26
    Ormerod E, McCandlish IA, Jarrett O. Diseases produced by feline caliciviruses when administered to cats by aerosol or intranasal instillation. Vet Rec 1979;104:6569.
  • 27
    Kahn DE, Hoover EA, Bittle JL. Induction of immunity to feline caliciviral disease. Infect Immun 1975;11:10031009.
  • 28
    Pedersen NC, Hawkins KF. Mechanisms of persistence of acute and chronic feline calicivirus infections in the face of vaccination. Vet Microbiol 1995;47:141156.
  • 29
    Povey RC, Hale CJ. Experimental infections with feline caliciviruses (picornaviruses) in specific-pathogen-free kittens. J Comp Path 1974;84:245256.
  • 30
    Wardley RC. Feline calicivirus carrier state: A study of the host/virus relationship. Arch Virol 1976;52:243249.
  • 31
    Povey RC, Koose H, Hays MB. Immunogenicity and safety of an inactivated vaccine for the prevention of rhinotracheitis, caliciviral disease, and panleukopenia in cats. J Am Vet Med Assoc 1980;177:347350.
  • 32
    Lazorowicz M, Steck F, Kihm U, et al. Respiratory infections of the cat: A serological survey in different populations. Zbl Vet Med B 1982;29:769775.
  • 33
    Gaskell CJ, Gaskell RM, Dennis PE, et al. Efficacy of an inactivated feline calicivirus (FCV) vaccine against challenge with United Kingdom field strains and its interaction with the FCV carrier state. Res Vet Sci 1982;32:2326.
  • 34
    Yamaguchi N, MacDonald DW, Passanisi WC, et al. Parasite prevalence in free-ranging farm cats, Felis sylvestris catus. Epidemiol Infect 1996;116:217223.
  • 35
    Ossiboff RJ, Parker JSL. Identification or regions and residues in feline junctional adhesion molecule required for feline calicivirus binding and infection. J Virol 2007;81:1360813621.
  • 36
    Stuart AD, Brown TDK. α2,6-Linked sialic acid acts as a receptor for feline calicivirus. J Gen Virol 2007;88:177186.
  • 37
    Elgavish A. Epigenetic reprogramming: A possible etiologic factor in bladder pain syndrome/interstitial cystitis. J Urol 2009;181:980984.
  • 38
    Fuginami RS, von Herrath MG, Christen U, et al. Molecular mimicry, bystander activation, or viral persistence: Infections and autoimmune disease. Clin Micro Rev 2006;19:8094.
  • 39
    Elbadawi A. Interstitial cystitis: A critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 1997;49 (Suppl 5A):1440.
  • 40
    Lavelle J, Meyers S, Ramage R, et al. Bladder permeability barrier: Recovery from selective injury of the surface epithelial cells. Am J Physiol Renal Physiol 2002;283:F242F253.
  • 41
    Sant GR, Kempuraj K, Marchand JE, et al. The mast cell in interstitial cystitis: Role in pathophysiology and pathogenesis. Urology 2007;69 (Suppl 4A):3440.
  • 42
    Westropp JL, Buffington CAT, Chew D. Feline lower urinary tract diseases. In EttingerSJ, FeldmanEC, eds. Textbook of Veterinary Internal Medicine, 6th ed. St Louis, MO: Elsevier Saunders; 2005:18281850.